3320 — China Resources Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$28.93bn
- HK$167.93bn
- CNY269.57bn
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million
Brief: China Resources Pharmaceutical Says QTRLY Net Profit For CR Double-Crane Is RMB501.4 MLN
Brief: China Resources Pharmaceutical Says QTRLY Net Profit For CR Jiangzhong RMB312.0 MLN
China Resources Pharma hits more than 4-month peak on higher FY profit, dividend
Brief: China Resources Pharmaceutical Posts FY Profit Attributable Of RMB4.05 Billion
Brief: China Resources Pharmaceutical Logs FY Revenue RMB2.06 Bln For CR Boya Bio-Pharmaceutical
Brief: China Resources Pharmaceutical Proposes Cash Dividend RMB14.31 Per 10 Shares Of Dong-E-E-Jiao
Brief: China Resources Pharmaceutical Says KPC Pharmaceuticals Proposes Dividend Of Rmb1.80 per 10 Shares
Brief: China Resources Pharmaceutical Discloses Potential Disposal Of Tianmai Biotechnology
Brief: China Resources Pharmaceutical Announces Potential Disposal Of Tianmai Biotechnology
Brief: China Resources Pharmaceutical Updates On KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By China Securities Regulatory Commission
Brief: China Resources Pharmaceutical Says CR Pharmaceutical Commercial May Issue Notes Up To RMB3 Billion
Brief: China Resources Pharmaceutical Says Fund Established With Proposed Size Of RMB500 Mln
Brief: China Resources Pharmaceutical Says 9M Net Profit For CR Boya Bio-Pharmaceutical At RMB343 Million
Brief: China Resources Pharmaceutical Posts 9M Results For China Resources Double-Crane Pharmaceutical